Opinion: SBA's reinterpretation halts many biotech research grants

09/7/2005 | San Diego Source (subscription required)

The Small Business Administration's reinterpretation of investor ownership requirements -- which now excludes any company more than 51% owned by venture capital firms -- has halted many biotech companies' research progress by preventing them from attaining Small Business Innovation Research grants. Dr. Elias A. Zerhouni, director of the National Institutes of Health, has appealed to SBA to reconsider the limitations, and two bills regarding this issue have been introduced to Congress.

View Full Article in:

San Diego Source (subscription required)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA